GENEVA (Reuters) - The Delta variant of COVID-19, first identified in India, is becoming the globally dominant variant of the disease, the World Health Organization's chief scientist said on Friday.
Soumya Swaminathan also voiced disappointment in the failure of CureVac's vaccine candidate in a trial to meet the WHO's efficacy standard, in particular as highly transmissible variants boost the need for new, effective shots.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
